Synthesis, antihypertensive activity, and 3D-QSAR studies of some new p-hydroxybenzohydrazide derivatives

Archiv der Pharmazie

Volumn 344, Issue 2, 2011, Pages 119-134

  Bhole, Ritesh P ^a   Bhusari, Kishore P ^a  

^a Nagar Yuwak Shikshan Sanstha   (India)

Author keywords

3D QSAR; Antihypertensive activity; PHASE program; Synthesis

Indexed keywords

4 HYDROXYBENZOHYDRAZIDE DERIVATIVE; 4 HYDROXYBEZOHYDRAZIDE; ALDEHYDE; ANTIHYPERTENSIVE AGENT; CARBON DISULFIDE; CHLOROACETIC ACID; HYDRAZIDE DERIVATIVE; ISOTHIOCYANIC ACID; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CYCLIZATION; DRUG SCREENING; DRUG SYNTHESIS; HYPERTENSION; INVASIVE PROCEDURE; MALE; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; SUBSTITUTION REACTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HYDRAZINES; MALE; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RATS, INBRED STRAINS;

EID: 79551706069     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000008     Document Type: Article

References (27)

1. C. Joao, D. Menezes, Am. J. Hypertens. 2003, 16, 1062-1065.
2. O. C. Kappe, Acc. Chem. Res. 2000, 33, 879-883.
3. M. Bordoloi, K. D. Roy, Indian J. Chem. 2006, 45B, 1067-1072.
4. G. B. Kumar, V. S. Mishra, Indian J. Chem. 2006, 45B, 2325-2331.
5. R. D. Bunag, J. Appl. Physiol. 1973, 34, 279-287.
6. R. D. Bunag, Cardiovasc. Res. 1971, 24, 213-220.
7. M. J. Fregly, Clin. Med. 1963, 62, 223-230.
8. Z. Xia, L. W. Hu, X. Wang, Bioorg. Med. Chem. 2007, 17, 3374-3377.
9. R. Vijaya, B. Narayana, B. Ashalatha, B. K. Sarojani, Eur. J. Med. Chem. 2007, 42, 425-429.
10. A. Badi, H. Eissa, A. A. Husain, Chem. Pharm. Bull. 2003, 51 (7), 833-847.
11. C. G. Bonde, N. J. Gaikwad, Bioorg. Med. Chem. 2004, 12, 2151-2161.
12. B. Narayana, B. V. Ashalatha, S. N. Kumari, Eur. J. Med. Chem. 2007, 42, 425-429.
13. S. V. Bhandari, A. A. Patil, A. P. Sarkate, S. G. Gore, K. G. Bothra, Bioorg. Med. Chem. 2009, 44, 390-400.
14. Y. S. Ke, X. Quin, N. Wang, Q. Yang, Eur. J. Med. Chem. 2008, 43, 1-9.
15. B. Narayana, B. V. Ashalatha, S. N. Kumari, Eur. J. Med. Chem. 2007, 42, 425-429.
16. T. A. Vincent, Int. J. Antimicrob. Agents 2003, 16, 317-324.
17. Y. T. Tan, D. Tillett, D. J. Mckay, Mol. Med. Today 2000, 6, 309-317.
18. A. M. Omar, N. H. Eshba, J. Pharm. Sci. 1984, 73, 1166.
19. R. P. Bhole, K. P. Bhusari, QSAR Comb. Sci. 2009, 12, 1405-1417.
20. R. P. Bhole, K. P. Bhusari, Digest J. Nano Biostruct. 2009, 4 (2), 329-338.
21. V. Raparti, T. Chitre, K. Bothara, V. Kumar, et al., Eur. J. Med. Chem. 2009, 44, 3954-3960.
22. R. Mukharji, M. Jaggi, S. K. Srivastava, Bioorg. Med. Chem. Lett. 2004, 14, 3169-3172.
23. L. Y. Hassan, A. A. Koussi, Z. S. Farghaly, Chem. Pharm. Bull. 1998, 46 (5), 863.
24. K. E. Kikuchi, M. Bernard, A. Sadownik, S. L. Regen, Antimicrob. Agents Chemother. 1997, 41, 1433.
25. PHASE 2.0, Schrödinger, LLC, New York, NY 2006.
26. R. P. Lee, D. Wang, H. I. Chen, J. Biomed. Sci. 2002, 9, 424-429.
27. Daylight chemical information systems 2000.